Huntington's Disease Clinical Trials Corner: August 2023.

ABSTRACT: In this edition of the Huntington's Disease Clinical Trials Corner, we expand on the GENERATION HD2 (tominersen) and on the Asklepios Biopharmaceutical/BrainVectis trial with AB-1001. We also comment on the recent findings from the PROOF-HD trial, and list all currently registered and ongoing clinical trials in Huntington's disease.

SUBMITTER: Estevez-Fraga C 

PROVIDER: S-EPMC10473124 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature